Zealand Pharma (Denmark) Price on December 1, 2024
ZEAL Stock | DKK 730.00 2.50 0.34% |
If you're considering investing in Zealand Stock, it is important to understand the factors that can impact its price. As of today, the current price of Zealand Pharma stands at 730.00, as last reported on the 2nd of December, with the highest price reaching 740.00 and the lowest price hitting 725.00 during the day. Zealand Pharma AS shows Sharpe Ratio of -0.0841, which attests that the company had a -0.0841% return per unit of risk over the last 3 months. Zealand Pharma AS exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Zealand Pharma's Mean Deviation of 2.17, standard deviation of 2.93, and Market Risk Adjusted Performance of (0.78) to validate the risk estimate we provide.
Zealand Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Zealand |
Sharpe Ratio = -0.0841
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ZEAL |
Estimated Market Risk
2.93 actual daily | 26 74% of assets are more volatile |
Expected Return
-0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Zealand Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zealand Pharma by adding Zealand Pharma to a well-diversified portfolio.
Zealand Pharma Valuation on December 1, 2024
It is possible to determine the worth of Zealand Pharma on a given historical date. On December 1, 2024 Zealand was worth 728.0 at the beginning of the trading date compared to the closed value of 730.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Zealand Pharma stock. Still, in general, we apply an absolute valuation method to find Zealand Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Zealand Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Zealand Pharma's related companies.
Open | High | Low | Close | Volume | |
735.00 | 742.00 | 725.00 | 730.00 | 70,969 | |
11/29/2024 | 728.00 | 740.00 | 725.00 | 730.00 | 135,228 |
728.00 | 740.00 | 725.00 | 730.00 | 0.00 |
Backtest Zealand Pharma | | | Zealand Pharma History | | | Zealand Pharma Valuation | Previous | Next |
Zealand Pharma Trading Date Momentum on December 1, 2024
On December 02 2024 Zealand Pharma AS was traded for 730.00 at the closing time. The highest price during the trading period was 740.00 and the lowest recorded bid was listed for 725.00 . There was no trading activity during the period 0.0. Lack of trading volume on December 2, 2024 had no short-term effect on price fluctuation. The trading date delta to the current price is 0.27% . |
Zealand Pharma AS Fundamentals Correlations and Trends
By evaluating Zealand Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Zealand Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Zealand financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Zealand Pharma Stock history
Zealand Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Zealand is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Zealand Pharma AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Zealand Pharma stock prices may prove useful in developing a viable investing in Zealand Pharma
Zealand Pharma AS, a biotechnology company, engages in the discovery, design, and development of peptide-based medicines in Denmark. The company was founded in 1997 and is headquartered in Copenhagen, Denmark. Zealand Pharma operates under Biotechnology classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 360 people.
Zealand Pharma Stock Technical Analysis
Zealand Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Zealand Pharma Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Zealand Pharma AS cannot be verified against its exchange. Please verify the symbol is currently traded on Copenhagen Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Zealand Pharma December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Zealand Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zealand Pharma shares will generate the highest return on investment. By undertsting and applying Zealand Pharma stock market strength indicators, traders can identify Zealand Pharma AS entry and exit signals to maximize returns
Zealand Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Zealand Pharma's price direction in advance. Along with the technical and fundamental analysis of Zealand Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Zealand to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.06) | |||
Jensen Alpha | (0.30) | |||
Total Risk Alpha | (0.74) | |||
Treynor Ratio | (0.79) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Other Information on Investing in Zealand Stock
Zealand Pharma financial ratios help investors to determine whether Zealand Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zealand with respect to the benefits of owning Zealand Pharma security.